Researchers at The Children’s Hospital of Philadelphia Research Institute are always curious as they explore uncharted territories and tap new technologies. Read about the many novel ways they are looking to improve children’s health in the February issue of Bench to Bedside.
The Kilbaugh Lab focuses on advanced therapies for treating cardiac arrest, traumatic brain injuries, cardiopulmonary bypass, extracorporeal life support, defense against chemical toxins, and therapeutics for mitochondrial disorders that reduce neurological damage.
The Wilson Lab studies the inherited neuro- and cardio-degenerative mitochondrial disorder, Friedreich ataxia (FA). The lab also constructed the first random shRNA-expressing libraries and is using these libraries for drug discovery in a variety of disorders.